Open access · CC-BY
via OpenAlex
Gut bacterial profiles in Parkinson's disease: A systematic review
Zhe Li, Hongfeng Liang, Lin Lu, Chunye Zheng, Yuzhen Fan, Bin Wu, Tao Zou, Xiaodong Luo, Zhang Xinchun, Yan Zeng, Ziyan Liu, Zhicheng Zhou, Zhenyu Yue, Yi Ren, Zhuo Li
CNS Neuroscience & Therapeutics · 2022 · ▲ 225 citations
Abstract
INTRODUCTION: Recent advances have highlighted the relationships between gut dysbiosis and Parkinson's disease (PD). Microbiota transplantation from PD patients to mice can induce increased alpha-synuclein-mediated motor deficits. Human studies have identified differences in the gut microbiota of PD patients compared to healthy controls. We undertook a systematic review to evaluate the available evidence for the involvement of gut bacteria in the etiology of PD. METHODS: The PubMed databank, the China National Knowledge Infrastructure databank, and Wanfang Data were searched from inception until June 2021 to identify human case-control studies that investigated relationships between PD and microbiota quantified from feces. We evaluated the resulting studies focusing on bacterial taxa that were different between PD patients and healthy controls. RESULTS: Twenty-six studies were found in which 53 microbial families and 98 genera exhibited differences between patients with PD and healthy controls. The genera identified by more than two studies as increased in PD were Bifidobacterium, Alistipes, Christensenella, Enterococcus, Oscillospira, Bilophila, Desulfovibrio, Escherichia/Shigella, and Akkermansia, while Prevotella, Blautia, Faecalibacterium, Fusicatenibacter, and Haemophilus had three or more reports of being lower in PD patients. More than one report demonstrated that Bacteroides, Odoribacter, Parabacteroides, Butyricicoccus, Butyrivibrio, Clostridium, Coprococcus, Lachnospira, Lactobacillus, Megasphaera, Phascolarctobacterium, Roseburia, Ruminococcus, Streptococcus, and Klebsiella were altered in both directions. CONCLUSION: Our review shows that the involvement of the gut microbiome in the etiology of PD may involve alterations of short-chain fatty acids (SCFAs)-producing bacteria and an increase in putative gut pathobionts. SCFAs-producing bacteria may vary above or below an "optimal range," causing imbalances. Considering that Bifidobacterium, Lactobacillus, and Akkermansia are beneficial for human health, increased Bifidobacterium and Lactobacillus in the PD gut microbiome may be associated with PD medications, especially COMT inhibitors, while a high level of Akkermansia may be associated with aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/cns.13990
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Li, Z., Liang, H., Lu, L., Zheng, C., Fan, Y., Wu, B., Zou, T., Luo, X., Xinchun, Z., Zeng, Y., Liu, Z., Zhou, Z., Yue, Z., Ren, Y., Li, Z., Su, Q., & Xu, P. (2022). Gut bacterial profiles in Parkinson's disease: A systematic review. <em>CNS Neuroscience & Therapeutics</em>. https://doi.org/10.1111/cns.13990
Vancouver
Li Z, Liang H, Lu L, Zheng C, Fan Y, Wu B, et al. Gut bacterial profiles in Parkinson's disease: A systematic review. CNS Neuroscience & Therapeutics. 2022. doi:10.1111/cns.13990.
BibTeX
@article{zhe2022Gutbac,
title = {Gut bacterial profiles in Parkinson's disease: A systematic review},
author = {Zhe Li and Hongfeng Liang and Lin Lu and Chunye Zheng and Yuzhen Fan and Bin Wu and Tao Zou and Xiaodong Luo and Zhang Xinchun and Yan Zeng and Ziyan Liu and Zhicheng Zhou and Zhenyu Yue and Yi Ren and Zhuo Li and Qiaozhen Su and Pingyi Xu},
journal = {CNS Neuroscience & Therapeutics},
year = {2022},
doi = {10.1111/cns.13990},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Psychiatry 2019
Open access · CC-BY
Systematic Review of Gut Microbiota and Major Depression
BMC Bioinformatics 2021
Open access · CC-BY
Dysbiosis of the gut microbiome is a risk factor for osteoarthritis in older female adults: a case control study
Journal of Cachexia Sarcopenia and Muscle 2021
Open access · CC-BY
Understanding the gut microbiota and sarcopenia: a systematic review
Journal of Personalized Medicine 2020
Open access · CC-BY
Gallstone Disease, Obesity and the Firmicutes/Bacteroidetes Ratio as a Possible Biomarker of Gut Dysbiosis
Nutrients 2019
Open access · CC-BY
Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia
European Journal of Clinical Nutrition 2021
Open access · CC-BY